Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

Diabetes is one of the biggest challenges of our generation, and I’m at heightened risk for developing it. As some MedShadow readers might already know, I am one of the many women with polycystic ovary syndrome (PCOS.) That condition puts me at a substantially higher risk than the average woman for developing diabetes. According to the Centers for Disease Control and Prevention (CDC), 4.8% of people between the ages of 18 and 40 (with or without PCOS), and 18.9% of those aged 45 to 64, in the U.S. have diabetes. But by the time they’re 40 years old, more than…

Read More

At MedShadow, we regularly interview patients about their experiences with medications. Time and time again, we have patients tell us that shortly after starting a new regimen, they gained weight. They don’t always know whether the drug directly caused their weight gain, but the timing is often suspect. Weight gain around your midsection is often associated with something called “insulin resistance,” a condition that researchers are finding more and more to be a side effect of drugs. Take Masonia Traylor, for example, who told MedShadow she gained 40 pounds after she switched to a new human immunodeficiency virus (HIV) medication.…

Read More

People on dialysis for kidney disease are 100 time more likely than others to get staph dangerous hospital- acquired infections in their blood. Nearly 15,000 dialysis patients got blood stream infections in 2020, a third of which were staph (infections of a bacteria called Staphylococcus aureus). While the number of infections has decreased since 2014, the risk remains, and disparities are prevalent. Black and Hispanic patients are more likely than their white counterparts on dialysis to get a staph in their bloodstream, according to a Centers for Disease Control and Prevention (CDC) report published February 6, 2023. You’ve been admitted…

Read More

Wegovy (semaglutide), a popular diabetes drug, has gotten a lot more popular over the last 18 months. In June 2021, it was approved for a new indication—weight loss for patients with obesity, even if they didn’t have diabetes. While it’s only indicated for those with obesity, celebrities with seemingly healthy weights have claimed to be giving themselves the at-home injections in hopes of fitting into particularly form-fitting outfits for special events. If you Google “wegovy” even once, you’ll likely start seeing ads on social media for telehealth companies that help manage weight, and of course, have doctors ready to prescribe…

Read More

​Early in Dee Mangin’s career as a primary-care physician, she noticed that many people, especially older adults, were prescribed large numbers and doses of drugs, which, in some cases, might actually be detracting from their health rather than improving it. Then, she realized that even when polypharmacy (being prescribed five or more medications simultaneously) was recognized as a problem, there wasn’t any systematic way to help patients and healthcare providers assess which medicines might be most effective in a lower dose or discontinued altogether.  Mangin is an MBChB (the New Zealand equivalent of an MD) and DPH (doctor of public…

Read More

✅ This article was reviewed and approved by Terry Graedon, member of our MedShadow Medical Advisory Board. Diabetes Drugs When Ron Carlson died on his motorcycle at 66, it wasn’t a slippery road or a distracted driver that led to his demise. It was hypoglycemia, according to the medical examiner who reviewed his death. Carlson, a diabetic, had been prescribed medication to lower his blood sugar, a job the drugs did too well. In Carlson’s case, it led to hypoglycemia that caused him to stumble, clutch the bike’s throttle for balance and then be flung across a restaurant parking lot.…

Read More

A Petition Was Filed For a Black Box Warning for SGLT-2 Inhibitors A petition was filed on June 24 that called for a black box warning for SGLT-2 inhibitors that are being prescribed for off-label used. The diabetes drug metformin is having a moment, as it may help stop COVID-19 deaths. And a cavalier and rebellious attitude in younger folks who think that they’re safe from COVID-19 may be the reason infection rates are surging in that demographic. The Dangers of a Common Diabetes Drug A citizen’s petition by Public Citizen was filed to the FDA on Wednesday, June 24,…

Read More

Your doctor has just prescribed you a diabetes medication. Here’s how they work to reduce blood glucose levels and what to be aware of while taking them. At a recent visit to the doctor’s office, I had blood drawn for a number of lab tests, including ones to detect diabetes. If you’re over 45 — like I am — you’ll probably be tested for diabetes at some point in time as well. Our risk factors for adult onset diabetes increase as we age. These risks include weight gain, poor eating habits, less active lifestyle and a family history of diabetes.…

Read More

If you’ve been diagnosed with type 2 diabetes, losing weight, exercising and changes in diet could be enough to keep your blood sugar in check. A combination of diet and exercise has the ability to reverse diabetes in many diabetics and pre-diabetics who are not insulin dependent — meaning if your pancreas is still producing any insulin. Since most diabetic medicines are taken for the rest of your life, it makes sense to delay taking them as long as healthfully possible. All medicines have side effects that might impair your life and taking drugs regularly adds a strain on your…

Read More

In the latest study, researchers at McGill University in Montreal found that Metformin, a commonly used drug to treat type-2 diabetes, increases the risk of low thyroid-stimulating hormone level in patients with underactive thyroids. In this study, 74,300 patients were given either Metformin or sulfonylurea, over a 25-year study period. In patients with treated hypothyroidism, Metformin monotherapy was linked with 55% increased risk of low TSH levels as compared to the use of sulfonuylurea. Via Science World Report. Posted September 26, 2014.

Read More